Jeffrey B. Kindler - 11 Jun 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Director
Signature
/s/ David Strauss, as Attorney-in-Fact for Jeffrey B Kindler
Issuer symbol
TERN
Transactions as of
11 Jun 2025
Net transactions value
$0
Form type
4
Filing time
12 Jun 2025, 17:43:49 UTC
Previous filing
16 May 2025
Next filing
01 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KINDLER JEFFREY B Director C/O TERNS PHARMACEUTICALS, INC., 1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY /s/ David Strauss, as Attorney-in-Fact for Jeffrey B Kindler 12 Jun 2025 0001174454

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TERN Stock Option (Right to Buy) Award $0 +45,000 $0.000000 45,000 11 Jun 2025 Common Stock 45,000 $4.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.